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Abstract
Protein misfolding disorders are associated with conformational changes in specific proteins, leading to the formation of
potentially neurotoxic amyloid fibrils. During pathogenesis of prion disease, the prion protein misfolds into b-sheet rich,
protease-resistant isoforms. A key, hydrophobic domain within the prion protein, comprising residues 109–122,
recapitulates many properties of the full protein, such as helix-to-sheet structural transition, formation of fibrils and
cytotoxicity of the misfolded isoform. Using all-atom, molecular simulations, it is demonstrated that the monomeric 109–
122 peptide has a preference for a-helical conformations, but that this peptide can also form b-hairpin structures resulting
from turns around specific glycine residues of the peptide. Altering a single amino acid within the 109–122 peptide (A117V,
associated with familial prion disease) increases the prevalence of b-hairpin formation and these observations are replicated
in a longer peptide, comprising residues 106–126. Multi-molecule simulations of aggregation yield different assemblies of
peptide molecules composed of conformationally-distinct monomer units. Small molecular assemblies, consistent with
oligomers, comprise peptide monomers in a b-hairpin-like conformation and in many simulations appear to exist only
transiently. Conversely, larger assemblies are comprised of extended peptides in predominately antiparallel b-sheets and are
stable relative to the length of the simulations. These larger assemblies are consistent with amyloid fibrils, show cross-b
structure and can form through elongation of monomer units within pre-existing oligomers. In some simulations,
assemblies containing both b-hairpin and linear peptides are evident. Thus, in this work oligomers are on pathway to fibril
formation and a preference for b-hairpin structure should enhance oligomer formation whilst inhibiting maturation into
fibrils. These simulations provide an important new atomic-level model for the formation of oligomers and fibrils of the
prion protein and suggest that stabilization of b-hairpin structure may enhance cellular toxicity by altering the balance
between oligomeric and fibrillar protein assemblies.
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Introduction
The assembly of specific protein molecules into amyloid fibrils
underlies several devastating neurodegenerative disorders, includ-
ing Alzheimer’s disease, Parkinson’s disease, Huntington’s disease,
amyotrophic lateral sclerosis and prion diseases [1]. The formation
of amyloid by protein misfolding is also believed to be causative in
a variety of non-neurodegenerative clinical syndromes, such as
type II diabetes [2]. The proteins within amyloid fibrils are in
predominately b-strand conformation and are organized into large
b-sheets; the b-strands run perpendicular to the axis of the fibril,
giving rise to the ‘‘cross-b’’ architecture that is characteristic of
amyloid. Many different proteins may contain short sections with
high propensity to form amyloid [3], however, recent investiga-
tions suggest that small, oligomeric or protofibrillar species, which
are structurally different to fibrils [4,5] are actually responsible for
the bulk of the cellular toxicity observed in protein misfolding
diseases [6,7,8,9]. It is critically important that we determine the
molecular mechanisms by which specific, normal, cellular
proteins, which comprise proteins from a disparate group of
sequences and cellular locations, misfold both into amyloid
structures that have a common macromolecular architecture and
also into cytopathic oligomeric structures. Prion diseases provide a
useful model system in this regard, since they are associated with
in vivo protein misfolding into aggregates that can be oligomeric,
fibrillar, neurotoxic and/or infectious, but the structures of such
forms remain obscure [10].
Prion diseases are also known as transmissible spongiform
encephalopathies and are associated with a conformational change
of the cellular prion protein, PrPC. The native protein is
structurally chimeric, composed of a partially-unstructured and
flexible N-terminal region coupled to a globular C-terminal region
by a short hydrophobic domain (Figure 1). The C-terminal region
of PrPC contains a 3-helix bundle with two short b-strands. During
prion disease, the protein misfolds into a structure that is
designated PrPSc and which contains substantially more b-sheet
structure at the expense of a-helix [11,12,13]. PrPSc contains a
protease-resistant core comprising residues ,90 to the extreme C-
terminus, indicating that the structural transition involves a short
section of the N-terminal domain, the hydrophobic region and the
PLOS ONE | www.plosone.org 1 January 2014 | Volume 9 | Issue 1 | e87354
entire C-terminal domain [14]. The atomic structure of PrPSc is
unknown, but modeling studies, based on computer simulation
with constraints derived from experiment, suggest that a b-helical
fold may be present [15]. In this b-helical fibril model, the b-
strands run perpendicular to the hypothetical fibrillar axis thereby
satisfying the criteria of cross-b structure of amyloid fibrils. It is
widely believed that the abnormal form of the prion protein acts as
a template upon which naı¨ve PrPC monomers can misfold [16].
The results of many recent studies suggest that this template-
directed, conformational change is a common facet of other
protein misfolding diseases [17,18,19,20,21,22,23,24,25].
The central hydrophobic domain of the prion protein has a
sequence that is highly conserved across all species studied to date
[26,27] and has properties that mimic those of the full molecule,
such as the ability to misfold and aggregate into amyloid fibrils
[28]. The core hydrophobic domain is composed of the residues
109–122 and was originally predicted to form an a-helical segment
in the full length protein (hence was given the designation H1)
[29]. A slightly longer version of this peptide, comprising residues
106–126, also misfolds and is associated with neurotoxicity [30].
Much research has focused on the conformations that can be
adopted by the 109–122 and 106–126 peptides by use of
biophysical techniques such as infrared spectroscopy, solution
and solid phase NMR and ion mobility mass spectrometry, as well
as a variety of molecular dynamics approaches
[31,32,33,34,35,36,37,38,39,40]. However, there has been a poor
consensus from these studies, most likely because the peptides are
conformationally flexible, the predominating conformation ap-
pears to depend strongly on solution conditions and many solution
phase techniques for measuring secondary structure report only at
the population average level. There have been corresponding
studies of the mechanisms of neurotoxicity and these studies
implicate deregulation of calcium ion homeostasis as a principal
driver of cell death, possibly through oligomeric forms of the 109–
122 and 106–126 peptides acting as integral-membrane ion
channels [41,42,43,44,45,46,47].
In this study, all-atom, Monte Carlo simulations have been
applied to study the conformations of the wildtype 109–122 and
106–126 peptides of murine PrP, as well as to equivalent peptides
carrying a mutation associated with inherited, human prion
disease. The simulations use a simplistic potential function that
speeds computation and allows the study of multiple copies of
peptides, thereby allowing models of aggregation to be explored.
However, this also necessitates that the results be interpreted with
care. Nevertheless, the energetically-favored conformation of all 4
monomeric peptides in implicit solvent was found to be essentially
wholly a-helical, but cluster analysis also revealed that each
peptide possess a small population of molecules in b-hairpin
conformations. The disease-associated mutation increases the
prevalence of b-hairpin forms of both 109–122 and 106–126
peptides, by increasing the energy of helical folds. Simulations of
multiple copies of either 109–122 or 106–126 peptide chains in a
periodic box show that transient dimers/trimers can form that are
composed of molecules in b-hairpin conformation and that such
assemblies can nucleate the formation of fibril-like aggregates
composed of cross-b peptide structures. However, also evident
during simulations are long-lasting, molecular assemblies, consis-
tent with oligomers and composed of peptides in b-hairpin
conformation. These data highlight b-hairpin structures as key
mediators of the aggregation of prion peptides and provide a
molecular basis for the assembly of such peptides into both
oligomers and fibrils.
Methods
2.1 Nomenclature
All simulations are based on peptide sequences derived from
murine prion protein corresponding to residues 109–122 or 106–
126. Mutated forms of both peptides were used and are given the
designations 109–122 A117V and 106–126 A117V. In all peptides
the N- and C-termini were derivatized with acetyl and amide
groups respectively. Thus, the sequences of the peptides used are:
109–122, Acetyl-LKHVAGAAAAGAVV-NH2; 109–122 A117V,
Acetyl-LKHVAGAAVAGAVV-NH2; 106–126, Acetyl-
KTNLKHVAGAAAAGAVVGGLG-NH2; 106–126 A117V, Ace-
tyl-KTNLKHVAGAAVAGAVVGGLG-NH2. Throughout this
paper the human numbering is used for consistency with other
papers in the field.
2.2 Molecular Simulations
All simulations were performed by use of the computer
modeling software Profasi, (available at http://cbbp.thep.lu.se/
activities/profasi/), the details of which have been previously
published [48,49]. Briefly, Profasi contains an implementation of
the all-atom, implicit solvent force field developed by Irback and
Mohanty to model the folding and aggregation of peptides ,20
residues in length. Most bond lengths and angles as well as peptide
torsion angles are fixed, such that each amino acid has the
Ramachandran angles Q and y, as well as some sidechain torsional
angles, as degrees of freedom. The interaction potential is
composed of terms describing local interactions, excluded volume,
hydrogen bonding and sidechain potentials and is described in
detail elsewhere [48]. Conformational aspects of peptide folding
are studied by Monte Carlo methods and each Monte Carlo step
involves variable updates of 3 different types, the probability of
each depending on the simulation temperature.
For simulations of monomers, the initial starting conformations
were chosen randomly and the simulation software calculated a
suitably sized box to contain the molecules during simulation. In
the case of the 109–122 and 109–122 A117V peptides, this box had
height, width and depth equal to 65.3 A˚ whilst for the longer 106–
126 and 106–126 A117V peptides each dimension was 91.9 A˚. For
multi-molecular simulations, 20 copies of each respective molecule
were used per simulation and each copy was assigned a random
starting conformation. The 20 molecules were placed into cubes in
which the height, width and depth dimensions were set to be equal
Figure 1. Sequence of the murine prion protein. The expressed
protein has N- and C-terminal signal peptides (italics) that are removed
during cellular processing. The N-terminal region is dynamically
unstructured, whilst the C-terminal domain possesses globular struc-
ture, including two short sections of b-strand (bold text) with three a-
helices (bold and underlined text). The hydrophobic peptide spanning
residues 105–125 is highlighted in black with white text; the peptide
spanning residues 108–121 is contained wholly within this peptide.
Note, these peptides are homologous to human residues 106–126 and
109–122 and different numbering results from different lengths of the
open reading frames. Throughout the rest of this paper the human
numbering is used for consistency with other papers in the field.
doi:10.1371/journal.pone.0087354.g001
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to 100 A˚ for all peptides. The effective concentration of each
peptide was therefore 33 mM, which equates to ,43 mg/ml for
the 109–122 and 109–122 A117V peptides and,63 mg/ml for the
106–126 and 106–126 A117V peptides. Monte Carlo simulations
of the monomeric peptides were calculated using simulated
tempering at 8 different temperatures, spaced equally between
277 K and 333 K (i.e. 277, 284, 292, 300, 308, 316, 324, 333 K).
Note that these temperature designations are nominal, but since
the computational model’s temperature scale has been previously
calibrated against 20mer peptides then it is expected that they will
be close to experimental values. Simulated tempering is similar to
replica exchange or parallel tempering, in that temperature acts as
a dynamic variable during the simulations, but in simulated
tempering only one replica of each molecule is used. During the
simulation the temperature can be altered to a neighboring
temperature with predetermined probabilities depending, in part,
on the total system energy. For simulations of each monomeric
system, probabilities were determined iteratively by performing a
series of short simulations and updating probabilities after each.
This allowed the final simulations to sample all temperatures with
roughly equal frequencies.
2.3 Analysis of Simulations
For simulations of monomeric structures, 16108 cycles were
performed corresponding to ,5.56109 or ,8.56109 elementary
Monte Carlo steps for the 109–122 and 106–126 peptides
respectively. Coordinate files were written every 1,000 cycles
yielding 100,000 structures per simulation. Structural and
energetic data relating to each structure were output to populate
histograms and this data was used for all graphical illustrations in
this manuscript, except where specified. For more detailed
structural analyses, every 20th structure was written to separate
pdb files, thereby yielding 5,000 structures per simulation, and
these were analyzed for hydrogen bond frequencies and to assign
structures to conformational clusters. Hydrogen bond frequencies
were calculated using MolMol and hydrogen bonds were deemed
to be present in a structure if the distance between donor and
acceptor atoms was 2.4 A˚ or less and the angle of the donor-
acceptor bond was not greater than 35u. Full lists of hydrogen
bonds found are available on request.
Initial clustering of structures was performed using Gromacs
(V4.6 [50]) using a cutoff of 2.5 A˚ for the 109–122 peptides and
3.5 A˚ for the 106–126 peptides. Clusters were compiled into larger
‘superclusters’ by means of a bespoke algorithm according to
criteria outlined in supplementary information. Multi-molecular
simulations were carried out at either 293 K or 303 K and were
performed for 26107 cycles, corresponding to ,2.461010 or
,3.561010 elementary Monte Carlo steps. Coordinates of all
atoms in the system were output every 500 cycles yielding 40,000
snapshots of the system over the course of each simulation.
‘Oligomerization’ of the peptide chains was monitored according
to previously published criteria [51,52]; briefly peptides were
assumed to be part of an oligomeric assembly if they were
connected to another chain by at least 3 hydrogen bonds,
possessed at least 50% b-sheet structure and were oriented either
parallel or antiparallel to each other to within 30u. For analysis
and the production of videos of the simulations, every 100th
coordinate set was used. Structural representations and videos of
multimolecular simulations were prepared by use of MolMol [53]
or Visual Molecular Dynamics [54].
Results
The central hydrophobic domain of PrPC appears to be capable
of conformational flexibility in solution, depending on the
environment, and structures ranging from a-helix, through
random coil to b-turn have previously been suggested. A
simulated-tempering, Monte Carlo approach was used to probe
the balance between these different structural forms for the 109–
122 peptide as well as for a mutated version of the peptide in
which alanine 117 was altered to a valine (A117V). This mutation
occurs in humans and is associated with the familial prion disease
Gerstmann-Stra¨ussler-Scheinker syndrome [55]. The full, ex-
pressed sequence of the murine prion protein, with the central
hydrophobic domain highlighted, is shown in figure 1.
3.1 The Wildtype 109–122 Peptide Preferentially Adopts
a-helical Structure
In all work detailed in this manuscript, the all-atom, implicit
solvent, molecular dynamics program Profasi has been used for
Monte Carlo simulations of peptide structure. This software uses
an implementation of a forcefield developed by Irback & Mohanty
[48]; whilst this forcefield is a rather simplified approximation and
may overstate electrostatic interactions, its speed allows studies
that are not possible using higher resolution models. For instance,
the software has previously been used to investigate differences in
structure and aggregation propensity between different sequences
of the Ab peptide that accumulates during Alzheimer’s disease
[52,56,57,58,59]. In the current study, the monomeric peptide
homologous to murine PrP residues 109–122 was simulated over
.109 discrete Monte Carlo steps, using a simulated tempering
approach in which different simulation temperatures were
sampled with predetermined probabilities. Every 1,000 steps, a
variety of information relating to the peptide sequence was output,
including the total energy and the amount of secondary structure
present.
By use of the molecular potential implemented within Profasi,
the wildtype 109–122 peptide is seen preferentially to adopt a-
helical conformations. Figure 2(A) shows the frequency that each
amino acid is in a-helical conformation as a function of simulation
temperature whilst Figure 2(C) shows the frequency of b-sheet
structure. Compared to the remainder of the peptide, the C-
terminal region has a reduced propensity for helical structure, but,
overall, there is an overriding preference for helical structure,
particularly at lower simulation temperatures. The lowest simu-
lation temperatures are associated with the lowest propensity for b-
sheet structure and as the simulation temperature increases so does
the frequency of b-sheet structure formation. However, it is
notable that b-structure is uniformly absent from the two central
glycine residues at all simulation temperatures.
The simulation of the 109–122 monomer was repeated 3 times
with comparable results. Within each of the 3 repeats, the lowest
energy conformer was ,100% a-helical and the lowest energy
conformer across all three replicate simulations is shown in
Figure 2(E). Also evident were low energy states having high levels
of b-sheet structure; these conformations predominately involved
hairpin turns. Across all 3 simulations of the wildtype 109–122
structure, the lowest energy b-hairpin structure involves a b-turn
around residues A115 and A116 and a schematic of this structure is
shown in Figure 2(F). To probe the overall energetics of the 109–
122 peptide, the average energy of the peptide was calculated as a
function of the fraction of amino acids in a-helical and b-sheet
structure. The 3-dimensional energy profile that results is shown in
figure 2(G) and contains energy minima corresponding to high
levels of a-helical structure or b-sheet structure respectively,
B-Hairpins Mediate Prion Association Mechanisms
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separated by a saddle point corresponding to random structures.
This suggests that structured conformers are energetically more
stable than random conformations. Furthermore, Figure S1(A) in
File S1 shows histograms depicting the distribution of peptide
energies at different temperatures and shows that at low simulation
temperatures, where many peptides have high helical structure,
peptides possess a general lower energy than high temperatures at
which random coil and sheet-containing structures predominate. If
we focus only on structures derived from simulation temperatures
of 284 or 292 K, the peptides segregate into those having high
helical content and low energies and those having essentially zero
helical content and higher energies (Figure S1 (B) in File S1).
However, a small number of peptides having no helical content
are seen to have low energies and these correlate to b-hairpin
isoforms. Overall, the peptide 109–122 preferentially forms helical
conformations but can also form b-hairpin structures having low
energies, whilst random coil structures are associated with higher
energies.
3.2 The Disease-associated Mutation A117V Increases b-
sheet Structure in the 109–122 Peptide by Reducing the
Thermodynamic Stability of Helical Forms
Three replicate simulations of the 109–122 peptide carrying the
disease-associated mutation A117V were carried out, in order to
determine the effect that this mutation may have on the
conformational dynamics. Similarly to the wildtype peptide, the
lowest energy conformation of the 109–122 A117V peptide, across
3 replicate simulations, is also ,100% a-helix, however there are
differences in the overall propensity for helical structure compared
to the wildtype peptide. For the mutated peptide, the frequencies
of a-helical and b-sheet structure at each amino acid, as a function
of simulation temperature, are shown in Figures 2(B) and 2(D)
respectively. Compared to the wildtype 109–122 peptide
(Figures 2(A) and 2(C)), the mutated peptide has a reduced
propensity to form a-helical structure at low temperatures,
coupled with a higher propensity for b-sheet structure at the same
temperatures. The reason for this alteration in conformational
dynamics is a reduction in the thermodynamic stability of helical
forms of the mutated peptide relative to the wildtype peptide.
Figure 2(H) shows the energy landscape as a function of a-helical
and b-sheet structure for the 109–122 A117V peptide; this shows a
similar overall profile to the energy landscape for the wildtype
peptide (Figure 2(G)), but the average energies of helical forms of
the 109–122 A117V structure is increased. This is in contrast to
other conformations, particularly b-sheet-containing structures,
which have similar energies to their wildtype counterparts. A
destabilization of helical forms can also be seen by comparing
energy distributions at low simulation temperatures (Figure S1 (A)
and (C) in File S1), which have higher energies relative to similar
simulations of the wildtype peptide. The 3-dimensional histograms
shown in Figure S1 (B) and (D) in File S1 also show that, for
peptide structures at simulation temperatures of 284 or 292 K,
there is a shift in the population of peptides from high helical
content to essentially zero helical content as a result of the
mutation. Thus, overall the A117V mutation destabilizes a-helical
folds and increases the proportion of other conformations in the
total population.
3.3 The A117V Mutation Increases the Percentage of
Conformers of the 109–122 Peptide having b-hairpin
Structure
Based on the increased preference for b-sheet formation and the
postulated ability of the 109–122 peptide to form b-hairpin
structures [40,60,61], it was hypothesized that the A117V mutation
in the 109–122 peptide quantitatively promotes the formation of
b-hairpin structures at the expense of helix. To test this, 5,000
structures were extracted at regular intervals from each replicate
simulation, yielding 15,000 independent structures for each of the
109–122 and 109–122 A117V peptides respectively. These
structures were first clustered, based on root-mean-squared
deviations in atomic coordinates, but this yielded many clusters
of ,5 structures each. The initial clusters were further amalgam-
ated based on the presence of particular secondary structural
motifs to produce 14 structural ‘superclusters’ associated with
specific structural elements and a 15th that accounted for all other
peptide structures (i.e. random coil). The details of this procedure
are given in the supplementary materials along with the theoretical
definitions of each of the superclusters and example structures
assigned to each (Table S1 in File S1).
The 14 structured superclusters of the 109–122 peptide
included several associated with a-helical structure as well as
superclusters involving b-hairpin structure. The superclusters were
further consolidated to produce 5 structural families corresponding
to structures that (i) were largely a-helical (ii) were b-hairpin in
structure with a turn comprising two or more of the residues 113–
116 (iii) were b-hairpin in structure with a turn comprising two or
more of the residues 117–119 (iv) were double b-hairpins with
turns at both residues 113–116 and 117–119 or (v) were random
coil. The percentage of structures present in each of these top level
families are shown in Table 1 for simulations of both the 109–122
and 109–122 A117V peptides. These data show clearly that the
A117V mutation results in an increase in the number of molecules
in b-hairpin conformation where the turn is around residues 113–
116 and there is an almost 2 fold greater number of molecules
having a double b-hairpin structure comprising two turns. There
are less structures having a-helical structure in the simulation of
the 109–122 A117V peptide relative to its wildtype counterpart and
overall these data suggest that the mutated peptide does indeed
lose helical structure but gains certain b-hairpin structures. To
allow more detailed comparisons of the results of the mutation,
Table S2 in File S1 shows the number of structures assigned to
each of the 15 superclusters, along with the fold change that
results.
b-hairpin structures divide into several different subsets
depending on the type of turn that links the antiparallel b-strands
of such structures. b-hairpin structures of the 109–122 and 109–
Figure 2. Analysis of Monte Carlo simulations of 109–122 and 109–122 A117V peptide monomers. (A) and (B) frequency of a-helical
structure around each amino acid as a function of temperature for 109–122 and 109–122 A117V peptides respectively. Simulation temperatures are
given in materials and methods and as the temperature is increased so the overall frequency of helical structure decreases. (C) and (D) frequency of b-
sheet structure around each amino acid as a function of temperature for 109–122 and 109–122 A117V peptides respectively. As temperature increases
the frequency of b-sheet also increases. (E) Schematic representation of the lowest energy conformation from the 3 replicate simulations of the
wildtype 109–122 peptide. The backbone of the peptide is highlighted (carbon atoms grey, oxygen atoms red, nitrogen atoms blue) and the peptide
is essentially 100% a-helical (F) schematic representation of the lowest energy conformer from the 3 replicate simulations of the wildtype 109–122
peptide in which b-sheet percentage is .50%. The peptide is in a b-hairpin conformation with a b-turn around residues Ala115 and Ala116. (G) and (H)
total energy as a function of the proportion of helical structure and the proportion of b-sheet structure in 109–122 and 109–122 A117V mutant
peptides respectively.
doi:10.1371/journal.pone.0087354.g002
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122 A117V peptide structures were analyzed to attempt to
determine whether particular types of turn predominated. Some
b-hairpin structures possessed a-turns, but the majority of
structures had b-turns, which comprise two residues in the turn
and hydrogen bonds linking residues i and i+3. Within this
population, a preference was found for b-turns of the II or II’ type,
however, in many structures the backbone Ramachandran angles
deviated substantially from the ideal angles for any of the
recognized b-turns [62]. This is probably a result of the
inflexibility of bond lengths and certain bond angles in the
computer model, as well as reflecting the dynamic nature of the
conformation of the peptide during Monte Carlo simulations at
higher temperatures. Nevertheless, II and II’ b-turns are preferred
in b-hairpin structures and henceforth the generic term ‘b-turns’
will be used to describe all turns linking antiparallel b-strands in b-
hairpin structures.
To confirm that the apparent increase in b-hairpin structures
were not artifacts of the clustering methodology, a second method
of analysis was used. The 5,000 structures from each simulation (3
replicate simulations each of 109–122 and 109–122 A117V) were
analyzed for frequently occurring hydrogen bonds. From such
data, it is possible to determine the change in percentage
occupancy of each hydrogen bond in the 109–122 peptide that
results from the A117V mutation. Those hydrogen bonds that show
a 2 fold change in percentage occupancy (or greater) are listed in
Table 2. Hydrogen bonds showing the largest changes tend to be
between main-chain atoms of residues that are some distance
apart in the linear structure. In other words, they are associated
with bonding between N- and C-terminal domains in a hairpin
structure. Table 2 also lists the approximate location of the turn in
hairpin peptides that would account for the hydrogen bonding
observed; for many of the hydrogen bonds undergoing the largest
fold change as a result of the A117V mutation, the turn would be
around residues 113–115. Thus, from the simulations undertaken
of the 109–122 and 109–122 A117V peptides, there is unequivocal
evidence that that the presence of the A117V mutation causes
increased prevalence of b-hairpin structure in the 109–122 peptide
at the expense of a-helical folds.
3.4 A Longer Peptide, Encompassing Residues 106–126,
Replicates the Behavior of the 109–122 Peptide
Much research in the prion field has focused on the structural,
fibrillogenic and neurotoxic properties of a longer version of the
109–122 peptide, comprising residues 106–126. To confirm results
obtained for the 109–122 peptide, the longer 106–126 peptide and
its mutated equivalent (106–126 A117V) were subjected to 3
replicate Monte Carlo simulations in Profasi. The results are
comparable to those generated from the 109–122 peptides in that
the peptide spanning residues 106–126 is preferentially a-helical
and the majority of low energy conformations have .90% helical
content. Apart from the extreme C-terminal amino acids, GGLG,
all residues show high frequencies of helix formation at low
temperatures, with helical content decreasing as temperature is
increased (Figure 3(A)). Levels of b-sheet, per residue, are low at
low temperatures and plateau as the temperature is increased
(Figure 3(C)). Similarly to the 109–122 A117V peptide, the mutated
106–126 A117V peptide has reduced levels of a-helix (Figure 3(B))
and higher levels of b-sheet (Figure 3(D)) in the central portion of
the peptide relative to the wildtype 106–126 peptide at the same
temperatures. The presence of the valine in the 106–126 A117V
peptide again results in a shift to higher energies at the lowest
temperature sampled (compare Figure S2 panels (A) and (B) in File
S1), whilst the higher temperatures, associated with random coil
structure, show little differences in energy. The energy landscapes
for the 106–126 and 106–126 A117V peptides also have minima
occurring at high levels of a-helix and of b-sheet structure (Figure
S2 (C) and (D) in File S1) and the mutation shifts the minimum
associated with high levels of helix to a higher energy. At
intermediate temperatures, the A117V mutation causes a decrease
in the number of structures populating helical states in favor of
high energy, unstructured forms and low energy b-sheet contain-
ing forms (Figure S3 in File S1).
To quantify the balance between populations of the different
structural conformers, 15,000 structures from the wildtype 106–
126 simulations and an equivalent number from the 106–126
A117V peptide simulations were clustered into 29 superclusters
(Tables S3 & S4 in File S1) and further consolidated to 6 structural
families, as outlined in Table 3. This includes different b-hairpin
forms with turns at 3 different locations (e.g. Figure 3(E) and (F)),
double hairpin (Figure 3(G)) and triple hairpin forms (Figure 3(H)).
As with the 109–122 peptide, the presence of the A117V mutation
in the 106–126 peptide caused increases in the propensity for
formation of b-hairpin forms at the expense of helical conformers.
This is also reflected in the change in hydrogen bond occupancies;
those hydrogen bonds that show the most dramatic changes in
occupancy as a result of the A117V mutation (Table 4) are
consistent with formation of b-turns around residues 113–115 and
119–121. These are the same locations in which b-turns are found
in the shorter 109–122 and 109–122 A117V peptides. In summary,
simulations of the monomeric wildtype 106–126 and mutated
106–126 A117V peptides replicate those of the shorter 109–122
and 109–122 A117V peptides, indicating that b-hairpin forms
represent a small subset of structures, but that the prevalence of
these forms increases after A117V mutation.
Table 1. Summary table of the average percentage of structures in different structural superclusters formed by the 109–122 and
109–122 A117Vpeptides during simulations.
Structural family description 109–122 (%) 109–122 A117V (%) Fold change
Family associated with a-helical structure 45.07 38.05 0.84
b-hairpin structures with b-turns around residues 113–116a 2.84 7.09 2.50
b-hairpin structures with b-turns around residues 117–119b 2.38 2.07 0.87
Double b-hairpin 1.15 2.15 1.88
Random coil 48.56 50.63 1.04
acomprises hairpin structures with b-turns at residues 113–114, 114–115 or 115–116.
bcomprises hairpin structures with b-turns at residues 117–118, or 118–119. Table S2 in File S1 lists all 15 superclusters individually along with the average percentage of
structures within each cluster.
doi:10.1371/journal.pone.0087354.t001
B-Hairpins Mediate Prion Association Mechanisms
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e87354
3.5 Multi-chain Simulations Indicate that the 109–122
Peptide can form Stable Fibrils Composed of Extended,
Anti-parallel b-strands in a Cross-b Architecture
The Profasi software provides the facility for simulating the
behavior of multiple peptide chains contained within a virtual
cube of defined dimensions. This allows the study of how peptides
may interact to form multi-molecular assemblies. To simulate
aggregation of the 109–122 peptide in implicit solution, 20 copies
of this peptide were placed within a virtual cube in which the
vertices each measured 100 A˚. 3 replicate simulations were
performed at 293 K and a further 3 were performed at 303 K.
These temperatures were chosen based on the results of
simulations of the peptide monomer; at these temperatures there
should be sufficient structural flexibility to populate many different
conformations over time, as well as sufficient translational motion
to allow peptide-peptide interactions to be sampled. Simulations
were performed for,2.361010 elementary Monte Carlo steps and
the total energy, percent of a-helical and b-sheet structure as well
as the extent of ‘oligomerization’ (defined in materials and
methods) were monitored at regular intervals. Short videos of all
multi-molecular simulations undertaken during this work are
available as supplementary materials (Video S1 through Video
S12).
Of the 6 multichain simulations of the 109–122 peptide, 3
showed no signs of aggregation and the population of peptides at
the end of the run contained disperse monomers in a range of
conformations (Table S5 in File S1). By contrast, the other 3
simulations showed a dramatic association of peptides into
ordered, b-sheet-containing structures. An example is shown in
Figure 4. Figure 4(A) shows the fraction of the peptides that are in
a-helical or b-sheet structure. From ,0.561010 steps there is an
increase in b-sheet structure at the expense of helical structure.
There is a concomitant reduction in the total energy of the system
(Figure 4(B)) and an increase in the number of oligomerized
peptides (Figure 4(C)). Snapshots of the peptide population over
the course of the simulation (Figure 4(D)) show clearly that
individual peptides adopt b-strand conformations and associate
into a single, large, multi-stranded b-sheet; in other simulations
more than one peptide assembly formed during the simulations.
Once these structures formed they were stable for the remainder of
the simulations and the final morphology (Figure 4(D) at
2.3261010 steps) is similar to a proteinaceous fibril, where b-
strands run perpendicular to the axis of the fibril.
The algorithm that monitors the association of peptides
distinguishes between b-strands that are parallel from those that
are antiparallel. In all of the simulations of the 109–122 peptide
that result in aggregation, there is an overriding preference for
antiparallel b-sheet formation (Figure 4(C)). Peptides are not all
‘in-register’, hence some seem to be off-set from the fibril axis
thereby producing deviations from an ideal fibrillar structure.
However, once they began to form, peptides associated into the
fibrillar structures rapidly and these structures were then stable for
the course of the simulations. This produced an association phase
that shows the classic sigmoidal geometry of fibril formation when
monitored by the conformational transition (Figure 4(A)), total
energy of the system (Figure 4(B)) and peptide associations
(Figure 4(C)). In addition, the absence of fibril formation in some
simulations, coupled with the rapid, sigmoidal association phase in
those simulations that do result in fibrils, is consistent with a
stochastic nucleation event preceding fibril formation, hence the
pre-association phase was carefully analyzed.
3.6 Prior to Fibrillization, Small Multimers of the 109–122
Peptide form Transiently and are Composed Partly of
Peptides in b-hairpin Conformation
The pre-association phase of multi-chain simulations of the
109–122 peptide is characterized by multiple inter-molecular
interactions. For the system shown in Figure 4, the steps
immediately prior to and spanning the initial association phase
were dissected in detail; 4,000 snapshots of the system covering the
period from 0.42–0.6561010 steps were analyzed for hydrogen
bonds between the different chains and some of the data that
resulted is shown in Figure S4 in File S1. Hydrogen bonds between
two specific chains were often relatively transient, often lasting
only 1 frame or so (equivalent to 66105 Monte Carlo steps).
However, in some cases, interactions were evident that persisted
over multiple frames (representing up to ,56107 elementary
Monte Carlo steps) as evidenced by many sequential frames in
which hydrogen bonds numbered .2–3. These interactions are
consistent with the formation of small oligomers (predominately
Table 2. Hydrogen bonds showing changes in occupancy .2 fold between 109–122 and 109–122 A117V peptide simulations.
Average hydrogen bond occupancyb
H-bond donora H-bond acceptora 109–122 (%) 109–122 A117V (%) Fold-change b-turn residues
K110 A118 0.09 0.57 6.07 113–115
A118 H111 1.02 3.75 3.67 113–115
H111 A118 0.55 2.00 3.67 113–115
G119 V122 0.31 1.11 3.53 n/a
V122 A/V117 1.03 2.97 2.90 119–120
A113 A116 1.58 4.51 2.86 114–115
K110 A/V117 0.40 0.94 2.35 113–114
A120 L109 0.30 0.70 2.33 114–115
A/V117 K110 0.95 2.2 2.32 113–114
A/V117 L109 0.47 1.04 2.23 112–114
ain all cases the hydrogen bond donor atoms were amide nitrogen atoms and acceptors were carbonyl oxygen atoms of the specified residues.
bhydrogen bond frequencies quoted are the average occupancies of the 3 discrete simulations for each peptide; each simulation contributed 5000 structures for
hydrogen bond determination.
doi:10.1371/journal.pone.0087354.t002
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Figure 3. Analysis of Monte Carlo simulations of 106–126 and 106–126 A117V peptide monomers. (A) and (B) frequency of a-helical
structure around each amino acid as a function of temperature for 106–126 and 106–126 A117V peptides respectively. Simulation temperatures are
given in materials and methods and as the temperature is increased so the overall frequency of helical structure decreases. (C) and (D) frequency of b-
sheet structure around each amino acid as a function of temperature for 106–126 and 106–126 A117V peptides respectively. As temperature increases
the frequency of b-sheet also increases. (E) Schematic representation of the 106–126 A117V peptide as a b-hairpin with a b-turn located around
residues 113–115. The backbone of the peptide is highlighted (carbon atoms grey, oxygen atoms red, nitrogen atoms blue) (F) Schematic
representation of the 106–126 A117V peptide as a b-hairpin with a b-turn around residues 118–119. (G) Schematic representation of the 106–126
A117V peptide as a double b-hairpin with b-turns around residues 113–114 and 119–120 (H) Schematic representation of the 106–126 A117V peptide
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dimers or trimers) and could be detected by quantifying hydrogen
bonds formed only between two specific chains. For example,
Figure S4(A) in File S1 shows all hydrogen bonds formed between
backbone atoms of chain A and any other backbone atoms in the
system. These data contain a sequential stretch of several frames
containing .2 hydrogen bonds at around 0.561010 steps. This is
caused by a two-way association with chain O, since a peak in the
number of hydrogen bonds specifically between these two chains
coincides with the prolonged interactions of chain A with the rest
of the system. Likewise, chain C has an extended sequence of
frames containing .3 hydrogen bonds around steps 0.4961010
steps resulting from an interaction with chain P (Figure S4 panel
(C) in File S1); chain Q undergoes 2 interactions with chains D
and N (Figure S4 panel (E) in File S1).
During simulations of the monomeric 109–122 peptide, the
most prevalent defined structures were a-helices and b-hairpins
(Table 1). Reasoning that hairpin structure may be important for
the formation of transiently-stable multimers, the frequency of
hairpin structures was analyzed over the same 4,000 snapshots of
pre- and mid-association phases of the fibrillizing multichain
system. In general, any given chain formed b-hairpin structure
regularly, but this structure existed only for single frames at a time
(Figure S4 panels (B), (D) and (F) in File S1). However, when small
oligomers were detected, at least one of the chains involved in the
aggregates existed in b-hairpin structure for a substantially greater
number of frames. For example, Figure S4(B) in File S1 shows that
chain O exists as a b-hairpin for almost the entire time that it is
associated with chain A and for some of this time chain A is also in
b-hairpin conformation. Chain P is in b-hairpin conformation
during its association with chain C (Figure S4(D) in File S1) and
chain N forms a b-hairpin structure during association with chain
Q (Figure S4(F) in File S1). Metastable multimers can form in
which neither partner is in hairpin conformation (e.g. chains Q &
D in Figure S4(F) in File S1), but such complexes do not persist for
more than a few sequential frames hence are not readily detected.
In other words, b-hairpin formation by at least one partner in an
oligomer appears important to produce a prolonged association.
Several examples of small multimers that form during the pre-
fibrillization stage, prior to 0.5461010 steps, are highlighted in
Figure 5 within the ellipses. These include two trimers in which
one of the partners adopts b-hairpin conformation (Figure 5 (A) &
(C)), as well as a dimer containing two b-hairpins and a dimer
containing no b-hairpins (both Figure 5(B)), demonstrating the
different generic structures of oligomers that can form and then
dissipate. By contrast, Figure 5(D) shows a trimer composed of
peptides in elongated b-strand conformations. This multimer
represents the nucleus of fibril formation for this simulation to
which other chains subsequently add; the nucleus forms initially as
a conformationally-flexible dimer to which the third chain adds,
thereby stabilizing the hydrogen bond network. The nucleus exists
as a trimer composed of extended b-strands for,108 Monte Carlo
steps before more chains begin to add to the ends of the growing b-
sheet. The major difference between this trimer and others that
form only transiently is that the peptide chains form extended b-
strands, rather than b-hairpins, allowing backbone-to-backbone
hydrogen bonds down the entire length of each peptide chain.
Thus, once small oligomers have formed, linearization of peptide
structure is an important step in fibrillogenic nucleus formation.
3.7 Hairpin Structures may be Required for Peptide
Docking to the Fibril, but then such Peptides at the
Termini of Fibrils Impede Elongation Until they form
Extended Structures
b-hairpin structures appear important during the pre-fibrilliza-
tion phase of growth to promote long-lived, intermolecular
interactions. b-hairpin conformations are also preferred substrates
to add to the ends of growing fibrils, since they already contain
sections of b-sheet. However, once peptides have added to the end
of the fibrils, b-hairpin structure inhibits further addition of
monomers. Figure 5 (E) & (F) show snapshots of the same 109–122
system discussed above shortly after nucleation of the fibril (at
0.553 and 0.64961010 steps respectively). Peptides in b-hairpin
conformation can clearly be seen at each end of the fibril. These
snapshots are taken from the region of the simulation encompass-
ing steps 0.5–0.761010 and it can be seen in Figure 4 (A–C) as well
as Figure S4 (A) & (C) in File S1 that there exists a pronounced
plateau in the elongation phase of fibril growth. The presence of
the b-hairpin structures at each end of the fibril prevent further
addition of monomer units until these peptides have undergone
conformational change to produce extended b-strands. Thus,
overall the pre-association phase is characterized by the formation
and dissipation of small oligomers composed partly of peptides in
as a triple b-hairpin conformation with b-turns around residues 113–114, 118–119 and 122–123. In all hairpin structures the b-turn incorporates one
of the glycine residues of peptide 106–126.
doi:10.1371/journal.pone.0087354.g003
Table 3. Average percentage of structures in superclusters formed by the 106–126 and 106–126 A117V peptides during
simulations.
Supercluster description 106–126 (%) 106–126 A117V (%) Fold change
Cluster associated with a-helical structure 50.47 44.47 0.88
Single b-hairpin with b-turns around residues 112–117a 1.19 2.75 2.32
Single b-hairpin with b-turns around residues 118–120b 1.55 1.91 1.24
Double b-hairpin with b-turns at residues 112–116 and/or 118–120 and/or
122–124c
0.77 2.44 3.16
Triple b-hairpin 0.02 0.23 11.67
Random coil 46.01 48.19 1.05
aComprises hairpin structures with b-turns at residues 112–114, 113–114, 114–115, 115–116 or 116–117.
bcomprises hairpin structures with b-turns at residues 118–119, 118–120 or 119–120.
ccomprises double hairpins that have turns at two of the locations detailed under a and b above or b-turns at residues 122–124.
doi:10.1371/journal.pone.0087354.t003
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b-hairpin conformation, whilst such hairpins must form linear b-
strands to allow fibril-like structures to form. A detailed video of
the pre- and mid-association phase of this system, which
demonstrates all the behavior discussed in the previous two
sections, is available as supplementary materials (Video S21).
3.8 The 106–126 Peptide forms Different Molecular
Assemblies Composed of b-hairpins, Extended b-strands
or Mixtures of these Structures
Multichain simulations of the 106–126 peptide have also been
carried out at both 293 and 303 K. Results, including final
ensemble morphologies, are shown in Table S5 in File S1 and
videos of all simulations are available as supplementary materials
(Videos S13 through S20). Unlike the shorter 109–122 peptide, the
106–126 peptide appears to associate more readily and all
multichain simulations resulted in the formation of multimeric
assemblies. However, the morphologies of these assemblies varied
between different simulations. The results of two such simulations
are depicted in Figure 6. The simulations result in a gradual
increase in b-sheet at the expense of a-helical structure (Figure 6(A)
and (D)) and a similarly gradual increase in chains associating into
multimers (Figure 6 (B) and (E)). Structurally-different multimeric
assemblies can form during the simulations, which, in common
with the 109–122 peptide, are associated with either b-hairpin
conformations or with linear b-strands. Figure 6(C) shows
snapshots from a simulation in which small oligomers formed
that were composed of b-hairpin conformations. These oligomers
persisted for more Monte Carlo steps than those formed by the
109–122 peptide, presumably because the longer 106–126 peptide
allows for greater numbers of hydrogen bonds between peptides.
In some cases the oligomers dissipated after being assembled for
several billion Monte Carlo steps.
By contrast, Figure 6(F) shows snapshots from a system in which
a large ‘fibrillar’ assembly forms composed principally of peptides
in extended b-strand conformations. The nucleus for formation of
this fibril is a small oligomer comprising 3–4 peptides in b-hairpin
conformation, suggesting that oligomers of this type may be
capable of initiating fibril formation if there is sufficient
conformational overlap between the monomer units in each
molecular aggregate. Indeed, other simulations of the 106–126
peptide show further evidence of ‘mixed’ assemblies comprising
peptides having either b-hairpin sections or extended b-strands
(Table S5 in File S1). The single replicate simulation in which
extensive fibrillization occurs shows a greater number of anti-
parallel b-strands compared to parallel, but overall it is difficult to
say whether parallel or anti-parallel b-strands are preferred. In
Table 4. Hydrogen bonds changing in occupancy .2 fold as a result of the A117V mutation in simulations of the 106–126 and
106–126 A117V peptides.
Average hydrogen bond occupancy b
H-bond donora H-bond acceptora 106–126 (%) 106–126 A117V (%) Fold-change b-turn residues
N108 A120 0.08 0.41 5.17 113–115
L109 A/V117 0.15 0.73 4.95 112–114
G119 T107 0.12 0.57 4.78 112–114
A120 N108 0.13 0.59 4.40 113–115
A118 H111 0.57 2.51 4.38 114–115
K110 A118 0.15 0.63 4.32 113–115
H111 A118 0.39 1.63 4.21 114–115
A/V117 L109 0.25 0.99 4.03 112–114
A113 A116 0.84 3.15 3.75 114–115
N108 G119 0.08 0.29 3.58 113–114
A120 L109 0.15 0.53 3.43 114–115
G123 A116 0.70 2.39 3.42 119–120
A116 G123 0.25 0.81 3.27 119–120
A118 V121 0.86 2.77 3.22 119–120
V122 A/V117 1.06 3.38 3.19 119–120
K110 A/V117 0.46 1.39 3.03 113–114
G123 A116 0.30 0.85 2.84 119–120
L125 G114 0.13 0.36 2.84 119–120
G119 V122 0.76 2.05 2.70 120–121
G119 N108 0.37 0.96 2.62 113–114
A/V117 K110 0.89 2.31 2.58 113–114
A116 G124 0.15 0.39 2.57 119–121
H111 A115 0.43 1.03 2.42 112–114
V112 A115 1.34 3.02 2.25 113–114
ain all cases the hydrogen bond donors were amide nitrogen atoms and acceptors were carbonyl oxygen atoms of the particular residues.
bhydrogen bond frequencies quoted are the average occupancies of the 3 discrete simulations for each peptide; each simulation contributed 5000 structures for
hydrogen bond determination.
doi:10.1371/journal.pone.0087354.t004
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summary, the 106–126 peptide can associate into structures
composed of b-hairpins, extended b-strands or mixtures of both
conformations. The contribution of each of these structures in the
growing aggregate appears down to both thermodynamic and
kinetic factors; if b-hairpin peptide can open to form linear b-
strands before addition of the next peptide to the growing
aggregate then fibril-like assemblies will predominate but if
peptides add rapidly to the growing aggregate then b-hairpin-
containing, oligomer-like structures will be preferred. This, in turn,
depends on the stability of b-hairpin structures.
3.9 Multichain Simulations Indicate that the A117V
Mutation may Reduce the Propensity of Peptides to
Fibrillize Whilst Aiding Oligomer Formation
Finally, multichain simulations of both the 109–122 A117V and
106–126 A117V peptides were carried out. In simulations of the
corresponding monomers, the A117V mutation enhanced forma-
tion of b-hairpin structure in both peptides. For the 109–122
A117V peptide, 3 of the 6 simulations resulted in fibril-like
assemblies at the end of the simulation period, a similar level of
fibrillization to the wildtype 109–122 peptide (Table S5 in File S1).
The 106–126 A117V peptide formed assemblies of molecules in b-
hairpin conformation in all 4 of the simulations performed.
Therefore, the mutation does not appear to affect the propensity
for the peptides to coalesce into multimers. However, the presence
of the A117V mutation in the 109–122 peptide appeared to reduce
the rate of fibril elongation. Table S5 in File S1 shows plots of the
extent of oligomerization of the peptide population over time for
all multimolecular simulations undertaken in this work; compared
to plots for the wildtype peptides, those for the mutated 109–122
peptides show a reduced rate of structural change as well as a
reduced rate of oligomerization after nucleation. This is consistent
with b-hairpin-mediated nucleation of oligomers being equally
efficient for both wildtype and mutated 109–122 peptides, whilst
the reorganization of peptides to form extended b-strands is more
efficient for the wildtype peptide than for the mutated peptide.
Incorporating the A117V mutation into the longer 106–126
peptide affects neither the initial nucleation of oligomerization nor
the subsequent growth phase, presumably because the multimers
formed in these simulations are composed largely of peptides in b-
hairpin conformation. Since the A117V mutation enhances b-
hairpin formation in the simulations of monomers of this peptide,
this result is not unexpected; indeed one may predict that b-
hairpin-containing oligomeric assemblies of this peptide may be
favored over fibril-like assemblies containing extended b-sheet
structures as is seen in the shorter peptide. Substantially more
repeat simulations may allow significant differences in the course
of multimerization to be elucidated. Thus, overall it appears that
the A117V mutation slows growth of fibril-like assemblies whilst not
Figure 4. In some multi-peptide simulations of the 109–122 peptide, large, multi-molecular assemblies are formed. The data in this
figure relates to replicate 1 at a simulation temperature of 293 K. (A) fraction of peptide having a-helical structure (6) or b-sheet structure (&) as a
function of Monte Carlo steps. (B) The total energy of the system as a function of Monte Carlo steps. (C) the amount of peptides in parallel b-sheets
(6) or in anti-parallel b-sheets (&) as a function of Monte Carlo steps. (D) Ribbon representations of snapshots of the system at regular points
throughout the simulation, as indicated.
doi:10.1371/journal.pone.0087354.g004
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affecting the formation or growth of b-hairpin-containing oligo-
mers.
Discussion
Throughout this study, simulations were performed by use of
software that implements a simplified, course-grained force field,
which has been optimized to describe the folding of small peptides
and proteins. Whilst the approximations used greatly increase the
speed of calculation, they may also result in incorrect treatment of
certain atomic interactions. The results must therefore be treated
with some caution and interpreted, where possible, in the context
of in vitro research; fortunately there exists several experimental
studies of prion peptide folding. In the current simulations, the
energetically most stable structure of both 109–122 and 106–126
peptides was found to be essentially 100% a-helix. However,
cluster analysis of 15,000 structures output from simulations at
regular intervals demonstrated a small but significant population
of conformers having b-hairpin structures, whilst the predominat-
ing conformation (statistically) was random coil. These results
seem in reasonable agreement with experiment; prion peptides can
form helical conformations in mixtures of water and trifluor-
oethanol, whilst in pure water the helical conformations are
replaced by higher levels of b-structure, possibly because the
peptides are already aggregating. It is possible that the force field
used in these simulations overestimates the prevalence of
‘structured’ conformations, because hydrogen bonding energies
are artificially high, but it is also possible that the balance of
conformational states predicted by simulation represent the true
ensemble adopted by the peptide in solution.
It should be noted that the formation of b-hairpins in prion
peptide has previously been suggested explicitly and implicitly in a
range of other studies, further serving to validate the current
simulations. In this work, b-hairpin structures varied in relation to
the number of turns – single, double and triple hairpin forms of
peptides were found – as well as the location of the turns, but the
majority of turns were of the b type and incorporated one of the
glycine residues of the peptides. Glycine residues are known to be
favored in b-turns as a result of the flexibility of the backbone
torsional angles [63] whilst alanine residues, that comprise the
central portion of the PrP peptides, are predominately helix-
favoring but are also capable of turn formation [64]. Substitution
of alanine 117 for valine, a mutation that is associated with
inherited prion disease in humans [55] and which leads to
enhanced toxicity of peptide aggregates in vitro [65], energetically
destabilized helical folds and increased the proportion of peptides
in b-hairpin conformation. This effect is in line with the known
preference for valine residues to be in b-strands instead of a-helix
[66]. Depending on the force field and solvent conditions used,
computer simulations have shown the potential for b-hairpin
formation in the peptides used in the current study
[37,60,61,67,68,69]. Furthermore, studies of synthetic peptides
have found evidence for b-hairpin formation in vitro in the 106–
126 peptide [40].
An increasing body of literature implicates b-hairpin formation
as an essential step in misfolding of a range of peptides associated
with amyloid formation such as Ab [70,71], amylin [72,73,74] and
the polyglutamine region of amyloidogenic huntingtin [75]. Thus,
there have been several suggestions that b-hairpin peptide
conformations may represent key intermediates that promote the
Figure 5. Molecular assemblies that form during the pre- and mid-association phase of fibrillization of the 109–122 peptide. (A–C)
Ribbon representations of transiently stable multimers formed prior to nucleation of fibrillization. Dimers and trimers form that are often composed,
partly, of peptides in b-hairpin conformation. (D) Ribbon representation of the trimer that represents the nucleus of fibril formation and is composed
of peptides that have formed linear b-strands. (E–F) Ribbon representations of the growing fibril shortly after nucleation occurred. Peptides that have
added to the ends of the growing fibril are often in b-hairpin conformation for a large number of Monte Carlo steps and inhibit addition of more
peptides until the b-hairpin peptides open to form extended b-strands.
doi:10.1371/journal.pone.0087354.g005
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nucleation of amyloid fibril formation. The current study supports
this hypothesis and outlines the molecular mechanisms of b-
hairpin mediated aggregation in unprecedented detail. In multi-
chain simulations of aggregation, both 109–122 and 106–126
prion peptides formed transiently-stable, oligomeric assemblies
that comprised at least one peptide in b-hairpin conformation. For
the 109–122 peptide, these oligomers often persisted for only a
short amount of simulation time, whilst for the longer peptide they
appeared more stable. However, both peptides also formed
assemblies with architecture more akin to that found in amyloid
fibrils, with characteristic cross-b structure and composed of
peptides in linear b-strand conformation. For the 109–122 peptide
the structural transition from b-hairpin-containing oligomer to
fibril occurred rapidly and completely, whilst the longer peptide
formed molecular assemblies composed of mixtures of b-hairpin
and linear b-strands. Whilst the b-hairpin-driven mechanism of
aggregation may be an artifact of the force field used for these
simulations (since it may overestimate the strength of backbone-
backbone hydrogen bonds), it should be noted that the same force
field has been used in other studies of aggregation in other
amyloid-prone peptide systems and has predicted somewhat
different mechanisms for initial coalescence of monomers
[51,52,58,59].
The formation of ‘oligomers’ consisting of b-hairpin structure
and fibrils consisting of linear b-strands is consistent with a wealth
of data on the role of hairpin formation in fibrillogenic peptides.
To undergo the transition from b-hairpin to linear b-strand, the
turn within hairpin peptides needs to straighten. This process can
be seen clearly in videos of the current simulations, available as
supplementary information, after hairpin peptides add to the ends
of the growing fibrils. But if the b-hairpin structures are not easily
able to ‘open up’ to form extended b-strands then this will have the
effect of slowing fibrillization kinetics. Stabilization of b-hairpin
structure has continually been found to inhibit the formation of
amyloid fibrils whilst promoting oligomer formation in Ab
[76,77,78,79,80], polyglutamine peptides [81] and the short
amyloidogenic peptide KFFE [82]. Moreover, peptides designed
to form b-hairpin structure can interfere with amylin and a-
Figure 6. Structurally-different multimeric assemblies of the 106–126 peptide can form during simulations. Panels (A–C) relate to
replicate 1 at 293 K, whilst panels (D–F) relate to replicate 1 at 303 K. (A) and (D) show the fraction of peptide that possesses a-helical structure (6)or
b-sheet structure (&) as a function of Monte Carlo steps. (B) and (E) show the extent of oligomerization of peptide chains into parallel (6) or anti-
parallel (&) b-sheets as a function of Monte Carlo steps. (C) and (F) show ribbon representations of the state of the peptide ensemble at regular time
points during each simulation. In panel (C), assemblies composed of peptides in b-hairpin conformation form roughly halfway through the simulation
period. In panel (F), a nucleus of peptides in b-hairpin conformation form early during the simulation and, eventually, peptides being to form a fibril-
like structure composed of b-strands.
doi:10.1371/journal.pone.0087354.g006
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synuclein fibrillization [83] and with Ab aggregation [84].
Conversely, conditions that reduce b-hairpin stability also increase
the rate of fibril formation [57,85]. Consistent with these reports,
the A117V substitution in the 109–122 peptide enhanced the
population of b-hairpin peptides and appeared to slow the
formation of fibril-like growth once nucleation had occurred.
There have also been reports that the same substitution enhanced
the formation of unstructured forms of the peptide [86]. Also
within the prion protein hydrophobic region, substitution of the
two central glycine residues reduces fibrillization, presumably by
reducing backbone flexibility. It is around these glycine residues
that the majority of b-turns occur. Collectively, these studies
appear to point to the importance of b-hairpin structure in
nucleating oligomer formation, but once oligomers have formed
the stable hairpin structures are less capable of maturing to form
bona fide amyloid fibrils. It is therefore interesting that disease-
associated mutations in other proteins also appear to shift the
balance of aggregation from fibrils to more toxic oligomers
[87,88,89].
It is pertinent to ask how generic – and physiologically relevant
– the current molecular description of oligomers and fibrils of the
prion hydrophobic domain is likely to be. Recent computational
studies of Ab aggregation have yielded similar mechanisms of
nucleated growth, in which b-hairpin-containing (or amorphous)
oligomers form rapidly, but fibril-like growth subsequently
requires the formation of extended b-strands to result in a fibril-
inducing seed [51,90,91]. This model of fibrillization is reinforced
by experimental evidence of several unrelated proteins that also
form precursor aggregates, which then reorganize into fibril-
competent structures [92,93,94]. For the prion hydrophobic
domain, there has also been experimental evidence for reorgani-
zation of peptide chains both after initial nucleation of fibril
formation and while the fibril is growing. This reorganization
involves reptation – a realignment of b-strands to produce a
regular alignment [95] – which in the case of prion peptide 109–
122 may ultimately result in the alignment of residue 117 in
peptide b-strands organised in an anti-parallel architecture
[33,96,97]. Anti-parallel strands with residue 117 in alignment
would theoretically produce a core hydrophobic region encom-
passing the palindromic sequence VAGAAAAGAV. This core
region has previously been suggested to be a key determinate of
both fibril formation and neurotoxicity of the 106–126 peptide
[98,99] and has also been shown experimentally to be the most
protected from hydrogen/deuterium exchange [100]. This core
region is critically important for b-hairpin formation in the current
study and this region may also form b-hairpins in the context of a
substantially longer prion fragment [101,102]. Thus, the current
data are consistent with both theoretical and experimental
observations of peptide misfolding and probably represent the
initial phases of fibril growth only, such that if the simulations
present herein were extended then they may result in alignment of
A/V117 in antiparallel strands by molecular rearrangements within
fibrils. It is also worth noting that whilst many studies of peptide
aggregation have found evidence for parallel architecture in b-
strands in fibrils, there have been a number of studies that identify
anti-parallel architecture as being important for fibril formation of
specific peptides, including several studies on prion peptides
[38,94] and Ab [103,104].
Finally, one key limitation of the Profasi software used for these
simulations is the move set; single-body rigid body translations are
used and when more than one molecule interacts then the
assembly is almost immobile in space. This effect can be visualized
in all videos where aggregation occurs, since the molecular
assembly appears spatially fixed once it has formed. In reality,
small movements are possible, but the reduced lateral movement
prevents the coalescence of multiple nuclei that may form
concomitantly. This will also prevent two larger fibrillar assemblies
coming together to form double layer sheets of the kind found
recently in amyloid-forming peptides, called steric zippers. Steric
zippers have been found in crystal structures of several amyloid-
forming peptides [38,105,106] and involve the interdigitation of
amino acid side chains between pairs of b-strands, thereby forming
hydrophobic interfaces from which water molecules are excluded.
Such structures are attractive explanations for fibril conformations
of proteins, since they can rationalize amyloid stability as well as
structural polymorphism seen in amyloid aggregates [107],
although it remains unclear whether dry, steric zipper interfaces
are formed only during in vitro crystallization [108]. In the current
study both b-hairpin-containing oligomers and extended confor-
mation fibrils have faces that could form steric zippers and it
would be interesting to extend the simulations to investigate
whether coalescence of individual fibers occurs. This could be
achieved if the simulation time is dramatically extended, if an
upgraded multi-molecular translation scheme is used or if the
preformed fibrils are moved to higher resolution molecular
dynamics packages for simulation.
In conclusion, this study has revealed a key molecular
mechanism of association of peptides derived from the hydropho-
bic region of the prion protein. b-hairpin conformations in
individual monomers is a critical step in both initial oligomer
formation as well as monomer addition to nucleated fibrils. The
data also suggest that conditions that stabilize b-hairpin structures
may slow fibril formation, but may also increase formation of
oligomers, the species that have repeatedly been reported to be
cytotoxic Nevertheless, b-hairpin formation in the hydrophobic
region of prion proteins could represent an important therapeutic
target to prevent protein misfolding during prion disease
pathogenesis.
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